{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Return to MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
  • Sign In
  • Home
  • Live
  • On-Demand
  • RSS/Grand Rounds
  • Non-Accredited
  • About
  • Contact Us
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

MD Anderson workforce members:  Select "MD ANDERSON LOGIN" and enter your MD Anderson email address and password.

Guests (all other than MD Anderson workforce members): Select "GUEST LOGIN" and enter your email address and password.

MD ANDERSON LOGIN
GUEST LOGIN
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • AA
  • AAS
  • ADN
  • BA
  • BS
  • BSN
  • DDS
  • DMD
  • DMin
  • DNP
  • DO
  • DrPH
  • DVM
  • DVM,PhD
  • EdD
  • JD
  • MA
  • MBA
  • MBBS
  • MBBS,MD
  • MD
  • MD, MBA
  • MD, MPH
  • MD, PhD
  • MDiv
  • MEd
  • MHA
  • MPA
  • MPH
  • MS
  • MSN
  • MSW
  • None
  • Other
  • PharmD
  • PharmD, PhD
  • PhD
  • PsyD
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Division of Cancer Medicine Grand Rounds


RSS

  • Overview
  • Faculty
  • Schedule
Add to Calendar Division of Cancer Medicine Grand Rounds 1/9/2024 8:00:00 AM 1/9/2024 9:00:00 AM America/Chicago For More Details: https://mdanderson.cloud-cme.com/course/courseoverview?EID=33292 Description: This series promotes a multidisciplinary approach to cancer care. Experts from various specialties collaborate to present a comprehensive view of cancer management. Learners stay informed with the latest developments in cancer research. Discussions will include recent clinical trials, emerging treatment modalities, and breakthroughs in cancer genetics and immunotherapy. Engagement in interactive ... Virtual false MM/DD/YYYY


Date & Location
Occurs every 2 weeks on Tuesday starting on 1/9/2024 at 8:00 AM
Tuesday, January 9, 2024, 8:00 AM - 9:00 AM, Virtual, Houston, TX

Target Audience
Specialties - Medical Oncology
Professions - Nurse - APRN, Nurse - RN, Physician (MD or DO), Physician Associate, Student or Trainee

Credits
AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)

Overview
This series promotes a multidisciplinary approach to cancer care. Experts from various specialties collaborate to present a comprehensive view of cancer management. Learners stay informed with the latest developments in cancer research. Discussions will include recent clinical trials, emerging treatment modalities, and breakthroughs in cancer genetics and immunotherapy. Engagement in interactive case discussions that highlight complex patient scenarios, sharing diagnostic and treatment strategies, and provide insights into the most recent guidelines and recommendations in cancer management.

Objectives
At the conclusion of this activity, learners will be able to:

  1. Utilize newly acquired tools and knowledge to formulate innovative and multifaceted therapeutic approaches for patients who exhibit resistance to existing targeted treatments.
  2. Synthesize the latest developments in clinical genomics into the process of treatment planning.
  3. Grasp the significance of cell signaling interactions between tumor and host (stroma) tissues in the discovery of fresh targets for advancing cancer therapies.

Registration
If you are interested in attending this series, contact Noelise Cornelius - Activity Coordinator  at [email protected] 

Accreditation

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.





Additional Information

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 




The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.



Mitigation of Relevant Financial Relationships


The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Varsha Gandhi, PhD
Professor and Chair, ad interim
MD Anderson Cancer Center
Activity Co-Director
Grant or research support-Clear Creek Bio|Consulting Fee-Winston & Strawn|Advisor-AbbVie Inc.|Grant or research support-AbbVie Inc.|Grant or research support-AstraZeneca US (Relationship has ended)|Consulting Fee-Clear Creek Bio|Honoraria-Dava (Relationship has ended)|Grant or research support-Loxo Oncology|Grant or research support-Pharmacyclics LLC|Grant or research support-Sunesis (Relationship has ended)|Honoraria-Sunesis (Relationship has ended)|Consulting Fee-Atomwise|Consulting Fee-HMP Education (Relationship has ended)
Robert A. Wolff, MD
Professor, GI Medical Oncology
The University of Texas MD Anderson Cancer Center
Activity Director
Nothing to disclose
Richard E. Champlin, MD
Professor of Medicine
Univ Texas MD Anderson Cancer Center
Other Planning Committee Member
Consulting Fee-Johnson & Johnson (any division) (Relationship has ended)|Consulting Fee-Osiris (Relationship has ended)|Consulting Fee-Sanofi Genzyme (Relationship has ended)|Other: Data Safety Monitoring Committee-Bluebird
Michael A. Davies, MD
Professor
MD Anderson Cancer Center
Other Planning Committee Member
Paid consultant-Roche|Advisor-Iovance|Grant or research support-Lead Pharma|Paid consultant-Pfizer Inc.|Paid consultant-Novartis Pharmaceuticals Corporation|Paid consultant-Bristol-Myers Squibb Company|Paid consultant-ABM Therapeutics|Grant or research support-ABM Therapeutics|Paid consultant-Apexigen|Grant or research support-Pfizer Inc. (Relationship has ended)
Funda Meric-Bernstam, MD
Chair, Invest. Cancer Therapeutics
The University of Texas MD Anderson Cancer Center
Other Planning Committee Member
Consulting Fee-AstraZeneca US|Consulting Fee-Biovica (Relationship has ended)|Consulting Fee-Black Diamond (Relationship has ended)|Consulting Fee-Eisai, Inc. (Relationship has ended)|Consulting Fee-F. Hoffmann La Roche (Relationship has ended)|Consulting Fee-Karyopharm Therapeutics (Relationship has ended)|Consulting Fee-Lengo Therapeutics (Relationship has ended)|Consulting Fee-LOXO-Oncology (Relationship has ended)|Consulting Fee-OnCusp Therapeutics (Relationship has ended)|Consulting Fee-Seattle Genetics, Inc.|Consulting Fee-Tallac Therapeutics (Relationship has ended)|Consulting Fee-Zentalis (Relationship has ended)|Consulting Fee-Zymeworks|Grant or research support-Aileron Therapeutics|Grant or research support-AstraZeneca US|Grant or research support-Bayer HealthCare Pharmaceuticals, Inc.|Grant or research support-Calithera|Grant or research support-CytomX Therapeutics|Grant or research support-Curis|Grant or research support-Daiichi Sankyo, Inc.|Grant or research support-Debiopharm|Grant or research support-eFFECTOR Therapeutics|Grant or research support-Genentech, Inc.|Grant or research support-Klus Pharma|Grant or research support-Novartis Pharmaceuticals Corporation|Grant or research support-Puma Pharmaceuticals|Grant or research support-Taiho Oncology, Inc.|Consulting Fee-GT Apeiron (Relationship has ended)|Consulting Fee-Menarini|Consulting Fee-Ecor1|Consulting Fee-Calibr (a division of Scripps Research),|Consulting Fee-LegoChem Bio|Consulting Fee-Theratechnologies|Honoraria-Dava Oncology (Relationship has ended)|Other: Travel Reimbursement-Dava Oncology (Relationship has ended)|Consulting Fee-Protai

Sort by: Date Name

Date Empty Column Title
    No activities are currently published for this month.
No upcoming dates have been setup.

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.
Houston, TX 77030
 Privacy policies   

©2023 The University of Texas MD Anderson Cancer Center
Contact Us: [email protected]

See us on Facebook See us on Twitter See us on Linked In See us on Instagram